George Byram, MD
Sports Medicine · Shreveport, LANPI 1992064026
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,851 of the $13,839 with a category attached, or 64.0%. 27 manufacturers reported payments, led by Stryker at 54.5% of the total. Reporting peaked in 2019 at $3,449 and has fallen 52.8% since, to $1,627 in 2025.
Across 243 payments — averaging $56.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$8K
- Midsouth Orthopedics Inc.$3K
- Arthrex$1K
- Anika Therapeutics, Inc.$404
- Exactech, Inc.$182
- Pacira Pharmaceuticals Incorporated$144
- plus $1K from 21 others
What the payments were for
- Travel & lodging$1,2449%
- Food & beverage$8,85164%
- Education$3,71927%
- Other$250%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 175 | $7,544 |
| Midsouth Orthopedics Inc. | 7 | $2,982 |
| Arthrex | 6 | $1,482 |
| Anika Therapeutics, Inc. | 4 | $404 |
| Exactech, Inc. | 1 | $182 |
| Pacira Pharmaceuticals Incorporated | 3 | $144 |
| Amgen(2 entities) | 8 | $120 |
| Medacta USA, Inc. | 1 | $115 |
| Johnson & Johnson(2 entities) | 4 | $101 |
| Smith+Nephew | 1 | $97 |
| Vericel Corporation | 4 | $88 |
| Sanofi-aventis U.S. LLC | 5 | $83 |
| Davol Inc. | 2 | $76 |
| Bioventus LLC | 3 | $58 |
| Curonix LLC | 1 | $46 |
| Sanara Medtech Inc. | 4 | $41 |
| Innovation Technologies Inc | 2 | $41 |
| Dynasplint Systems Inc. | 2 | $41 |
| Nalu Medical, Inc. | 1 | $39 |
| Abbott | 2 | $34 |
| Welch Allyn | 1 | $25 |
| UCB, Inc. | 1 | $20 |
| Vertex | 1 | $19 |
| Heron Therapeutics, Inc. | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Axogen | 1 | $13 |
| Pacira Therapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,839 in reported general payments places this provider in the 75th percentile of 82 sports medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 159 | $1,812 |
| Ketorolac Tromethamine | 83 | $1,258 |
| Cyclobenzaprine Hcl | 295 | $1,149 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 153 | $849 |
| Methylprednisolone | 60 | $292 |
| Meloxicam | 101 | $243 |
| Ibuprofen | 21 | $113 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $105 |
| Indomethacin | 11 | $100 |
| Nabumetone | 12 | $68 |
| Tizanidine Hcl | 20 | $67 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $28 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Shreveport
- Mario Lobao GoncalvesShreveport$32K
- Kyle PlanchardShreveport$29K
- Richard BartonShreveport$9K
- Carlton HoutzShreveport$3K
- Naina Bouchereau-LalShreveport$1K
- Charles WebbShreveport$980
- Felix SavoieNew Orleans$1.4M
- Misty SuriNew Orleans$1.2M
- Michael ObrienNew Orleans$391K
- Brett CascioLake Charles$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.